Why the study?
How should lidocaine be used for the treatment and prevention of ventricular arrhythmias?
How should lidocaine be used for the treatment and prevention of ventricular arrhythmias?
Lidocaine is established as a safe and highly effective antiarrhythmic agent for managing ventricular arrhythmias in acute care settings.
Answers are grounded in this paper and cite their sources.
Supports lidocaine as first-line agent for life-threatening ventricular arrhythmias in acute settings; confirms its established role in Level 1 guidelines.
ALTHOUGH lidocaine hydrochloride was synthesized as a local anesthetic drug in 1943, its antiarrhythmic property was not recognized until the late 1950s, when anesthesiologists used the drug in the operating room for treating ventricular arrhythmias that occurred during the course of open heart surgery.¹In 1963, a detailed study²reported the comparison of lidocaine with procainamide for treating intraoperative and postoperative ventricular arrhythmias in patients undergoing cardiac surgery. This study demonstrated that lidocaine was safe, highly effective, and preferable to procainamide for such arrhythmias. With the development of the coronary care unit during the 1960s, lidocaine was found to be an important agent in controlling life-threatening arrhythmias,³and in 1967, its use for the treatment of less serious ventricular rhythm disturbances, which frequently herald the development of life-threatening arrhythmias, was proposed.⁴Subsequently, it gained general acceptance in the coronary care unit for both treating and preventing
No takes yet. Share an insight, caveat, or question.
Donald C. Harrison (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: